Human B Cells: Differentiation and Neoplasia

References

• Calvert J. E., Maruyama S., Tedder T. F., Webb C. F., Cooper M. D. Cellular events in the differentiation of antibody secreting cells. Semin. Haematol. 1984; 21(4)226–243
   PubMed Web of Science ®Google Scholar
• Vogler L. B., Lawton A. R. Ontogeny of B cells and humoral immune functions. Clinics in Immunol. Allergy 1985; 5(2)235–252
   Web of Science ®Google Scholar
• Zola H. Differentiation and maturation of human B lymphocytes: a review. Pathology 1985; 17: 365–381
   PubMed Web of Science ®Google Scholar
• Cooper M. D. B lymphocytes. Normal development and function. New Engl. J. Med. 1987; 317(23)1452–1456
   PubMed Web of Science ®Google Scholar
• Zola H. The surface antigens of human B lymphocytes. Immunology Today 1987; 8(10)308–315
   PubMedGoogle Scholar
• Leukocyte Typing II. Volume 2. Human B Lymphocytes, E. L. Reinherz, B. F. Haynes, L. M. Nadler, I. D. Bernstein. Springer Verlag, New York 1986
   Google Scholar
• McMichael A. J., Beverley P. C. L., Cobbold S., Crumpton M. J., Gilks W., Gotch F. M., Hogg N., Horton M., Ling N., MacLennan I. C. M., Mason D. Y., Milstein C., Spiegelhalter D., Waldmann H. Leucocyte Typing III. White cell differentiation antigens. Oxford University Press, Oxford 1987
   Google Scholar
• Knapp W. 4th International conference on human leucocyte differentiation antigens. Tissue Antigens 1989; 33: 49–365
   PubMedGoogle Scholar
• McKenzie I. F. C., Zola H. Monoclonal antibodies to B cells. Immunology Today 1983; 4: 10–15
   PubMedGoogle Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70(5)1316–1324
   PubMed Web of Science ®Google Scholar
• Letarte M., Vera S., Tran R., Addis J. B. L., Onizuka R. J., Quankenbush E. J., Jongeneel C. V., McInnes R. R. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 1988; 168: 1247–1253
   PubMed Web of Science ®Google Scholar
• Jongeneel C. V., Quackenbush E. J., Ronco P., Verroust P., Carrel S., Letarte M. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutal endopeptidase activity. J. Clin. Invest. 1989; 83: 713–717
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Brown G., Rapson Lister T.A. Antisera to an antigen on acute lymphoblastic leukaemia cells. Clin. Immunol. Immunopathol. 1975; 4: 67–84
   PubMedGoogle Scholar
• LeBien T. W., McCormack R. T. The common acute lymphoblastic leukaemia antigen (CDlO)-emancipation from a functional enigma. Blood 1989; 73(3)625–635
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M-T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., The French-American-British Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol. 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Grogan T. M. Calla-positive myeloma: an aggressive subtype with poor survival. Blood 1985; 66: 229–232
   PubMed Web of Science ®Google Scholar
• Katz F. E., Tindle R., Sutherland D. R., Greaves M. F. Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res. 1985; 9(2)191–198
   PubMed Web of Science ®Google Scholar
• Bollum F. J. Terminal deoxynucleotidyl transferase as a hemopoietic cell marker. Blood 1979; 54: 1203–1215
   PubMed Web of Science ®Google Scholar
• Coleman M. S., Hutton J. J. Terminal transferase. The Leukaemic Cell, Catovsky. Churchill Livingstone, Edinburgh 1981; 203–219
   Google Scholar
• Hollander Z., Shah V. O., Civin C. I., Loken M. R. Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow. Blood 1988; 71(2)528–531
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Penta A., Isaacs C. Cloning of CD19, a family of immunoglobulin-like proteins, and use of transfected cell lines to examine the workshop panel of monoclonal antibodies. Tissue Antigens 1989; 33(2)140a
   Google Scholar
• Shields J. G., Rigley K. P., Callard R. E. Regulation of human B cell proliferation and differentiation by the CD19 cell surface glycoprotein. Tissue Antigens 1989; 33(2)145a
   Google Scholar
• Uckun F. M., Jaszcz W., Ambrus J. L., Fauci A. S., Gajl-Peczalska K., Song C. W., Wick M. R., Myers D. E., Waddick K., Ledbetter J. A. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 1988; 71(1)13–29
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Penta A. Structure of the CD20 antigen and gene of human and mouse B cells and use of CD20 transfected cell lines to examine the workshop panel of antibodies. Tissue Antigens 1989; 33(2)140a
   Google Scholar
• Tedder T. F., Bell P. D., Frizzell R. A., Bubien J. K. CD20 directly regulates ion flux in B lymphocytes. Tissue Antigens 1989; 33(2)145a
   Google Scholar
• Tedder T. F., Klejman G., Schlossman S. F., Saito H. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J. Immunol. 1989; 142(7)2560–2568
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Disteche C. M., Louie E., Adler D. A., Croce C. M., Schlossman S. F., Saito H. The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site. J. Immunol. 1989; 142(7)2555–2559
   PubMed Web of Science ®Google Scholar
• Valentine M. A., Meier K. E., Clark E. A. Protein kinase C regulates phosphorylation of the CD20 phosphoprotein on B lymphocytes. Tissue Antigens 1989; 33(2)147a
   Google Scholar
• Valentine M. A., Cotner T., Gaur L., Torres R., Clark E. A. Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate. Proc. Natl. Acad. Sci. USA 1987; 84: 8085–8089
   PubMed Web of Science ®Google Scholar
• Nadler L. M. B cell/leukemia panel workshop: summary and comments. Leukocyte Typing II, Reinherz, et al. B Lymphocytes. 1986; Vol. 2: 3–43
   Google Scholar
• Ling N. R., MacLennan I. C. M., Mason D. Y. B-cell and plasma cell antigens: new and previously defined clusters. Leucocyte Typing III, McMichael, et al, 1988; 302–335, Ch. 7
   Google Scholar
• Mason D. Y., Stein H., Gerdes J., Pulford K. A. F., Ralfkiaer E., Falini B., Erber W., Micklem K., Gatter K. C. Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood 1987; 69(3)836–840
   PubMed Web of Science ®Google Scholar
• Proceedings of 4th International Conference on Human Leucocyte Differentiation Antigens, Vienna, February, 21–25th1989
   Google Scholar
• Defrance T., Aubry J. P., Rousset F., Vanbervliet B., Bonnefoy J. Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K., De Vries J., Banchereau J. Human recombinant interleukin 4 induces Fcϵ receptors (CD23) on normal human B lymphocytes. J. exp. Med. 1987; 165: 1459–1467
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D. A., Mann K. P. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. exp. Med. 1985; 162: 45–59
   PubMed Web of Science ®Google Scholar
• Yukawa K., Kikutani H., Owaki H., Yamasaki K., Yokata A., Nakamura H., Barsumian E. L., Hardy R. R., Suemara M., Kishimoto T. A B-cell specific differentiation antigen, CD23, is a receptor for IgE (FcϵR) on lymphocytes. J. Immunol. 1987; 138: 2576–2580
   PubMed Web of Science ®Google Scholar
• Yokata T., Arai N., De Vries J., Spits H., Banchereau J., Zlotnik A., Rennick D., Howard M., Takebe Y., Miyatake S., Lee F., Arai K-i. Molecular biology of interleukin-4 and interleukin-5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol. Rev. 1988; 102: 137–187
   PubMed Web of Science ®Google Scholar
• Gordon J., Flores-Romo L., Cairns J. A., Millsum M. J., Lane P. J., Johnson G. D., MacLennan I. C. M. CD23: a multi-functional receptor/lymphokine?. Immunol. Today 1989; 10(5)153–157
   PubMedGoogle Scholar
• Kikutani H., Yokota A., Tanaka T., Uchibayashi N., Sugiyama K., Barsumain E. L., Suemura M., Kishimoto T. Expression, structure and function of two species of Fcϵ receptor II (Fcϵ)/CD23, FcϵRIIa and FcϵRIIb. Tissue Antigens 1989; 33(2)134a
   Google Scholar
• Kikutani H., Inue S., Sato R., Barsumian E. L., Owaki H., Yamasaki K., Kalaho T., Uchibayashi N., Hardy R. R., Hirano T., Tsunasawa S., Saklyama F., Suemara M., Kishimoto T. Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell 1986; 47: 657–665
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Seed B. Molecular cloning of CD38. Tissue Antigens 1989; 33(2)139a
   Google Scholar
• Thompson L. F., Ruedi J. M., Glass A., Lucas A. H. Production of monoclonal antibodies to ecto-5'-nucleotidase (ecto-5'-NT): A glycosyl-phosphatidylinositiol (G-PI)-anchored differentiation antigen expressed on human T and B lymphocytes. Tissue Antigens 1988; 33: 163
   Google Scholar
• Narni F., Kudo J., Mars W., Calabretta B., Florine D. L., Barlogie B., Saunders G. F. HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia. Blood 1986; 68(2)372–377
   PubMed Web of Science ®Google Scholar
• Narni F., Selvanayagam P., Barlogie B., Saunders G. F. HLA-associated invatiant chain gene expression in human B cell neoplasia. Leukemia 1987; 1(6)504–507
   PubMed Web of Science ®Google Scholar
• Erickstein B. K., Asheim H. C., Smeland E. B., Beiske K., Funderud S. Characterization of a new monoclonal antibody HH2 which recognises a cell cycle regulated antigen specific for human B-lymphocytes. Tissue Antigens, 33(2)150a
   Google Scholar
• Moller P., Moldenhauer G., Dorken B. Workshop antibodies B29 (HD66) and B74 (CRIS-4) define a new B-cell antigen. Tissue Antigens, 33(2)160a
   Google Scholar
• Gregory C. D., Tursz T., Edwards C. F., Tetaud C., Talbot M., Caillou B., Rickinson A. B., Lipinski M. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol. 1987; 139: 313–318
   PubMed Web of Science ®Google Scholar
• Fellous M., Cartron J-P., Weils J., Tursz T. A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pk red blood cell specificity. Br J. Haematol. 1985; 60: 559–565
   PubMed Web of Science ®Google Scholar
• Funderud S., Blomhoff H. K., Asheim H. C., Beiske K., Totterman T., Smeland E. B. Characterization of a new non-clustered B cel specific antigen (FN1) preferentially expressed on resting cells. Tissue Antigens 1989; 33(2)151a
   Google Scholar
• Blatt J., Reaman G., Poplack D. G. Current concepts: Biochemical markers in lymphoid malignancy. New Engl. J. Med. 1980; 303(16)918–922
   PubMed Web of Science ®Google Scholar
• Kinet J-P. Antibody-cell interaction: Fc receptors. Cell 1989; 57: 351–354
   PubMed Web of Science ®Google Scholar
• Vitetta E. S., Brooks K., Isakson P., Layton J., Pure E., Yuan D. B lymphocyte receptors. Fundamental Immunology, W. E. Paul. Raven Press, New York 1984; 221–243
   Google Scholar
• McCulloch E. A. Stem cells in normal and leukaemic hemopoiesis. Blood 1983; 62(1)1–13
   PubMed Web of Science ®Google Scholar
• Vogler L. Bone marrow B cell development. Clinics in Haematol. 1982; 11(3)509–529
   PubMedGoogle Scholar
• Izaguirre C. A. Colony formation by lymphoid cells. Clinics in Haematol. 1984; 13(2)405–422
   PubMedGoogle Scholar
• Civin C. I., Banquerigo M. L., Strauss L. C., Loken M. R. Antigenic analysis of haematopoiesis VI. Flow cytometric characterization of My-10 positive progenitor cells. Exp. Hematol. 1987; 15: 10
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Waldmann T. A. Immunoglobulin genes. J. Clin. Immunol. 1984; 4: 1–11
   PubMed Web of Science ®Google Scholar
• Cooper M. D. Pre-B cells: normal and abnormal development. J. Clin. Immunol. 1981; 1(2)81–89
   PubMed Web of Science ®Google Scholar
• Gordon J. Molecular aspects of immunoglobulin expression by human B cell leukaemias and lymphomas. Adv. Cancer Res. 1984; 41: 72–154
   Google Scholar
• Greaves M. F., Hariri G., Newman R. A., Sutherland D. R., Ritter M. A., Ritz J. Selective expression of the common acute lymphoblastic leukaemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 1983; 61: 628
   PubMed Web of Science ®Google Scholar
• Ryan D., Kossover S., Mitchell S., Frantz C., Hennessy L., Cohen H. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 1986; 68(2)417–425
   PubMed Web of Science ®Google Scholar
• Kincade P. W. Formation of B lymphocytes in fetal and adult life. Adv. Immunol. 1981; 31: 177–245
   PubMed Web of Science ®Google Scholar
• Campana D., Patel M., Janossy G. The expression of antigens detected by B cell associated reagents of the B 'blind' panel during B cell differentiation. Tissue Antigens 1989; 33(2)173a
   Google Scholar
• Pabst R. The spleen in lymphocyte migration. Immunol. Today 1988; 9: 43–46
   PubMedGoogle Scholar
• Stein H., Gerdes J., Mason D. Y. The normal and malignant germinal centre. Clincs in Haem. 1982; 11(3)531–559
   PubMedGoogle Scholar
• Gadol N., Peacock M. A., Ault K. A. Antigenic phenotype and functional characterization of human tonsil B cells. Blood 1988; 71(4)1048–1055
   PubMed Web of Science ®Google Scholar
• MacLennan I. C. M., Gray D. Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 1986; 91: 61–85
   PubMed Web of Science ®Google Scholar
• Gathings W. E., Lawton A. R., Cooper M. D. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur. J. Immunol. 1977; 7: 804–810
   PubMed Web of Science ®Google Scholar
• Jelinek D. F., Lipsky P. E. Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv. Immunol. 1987; 40: 1–59
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Ann. Rev. Immunol. 1988; 6: 485–512
   PubMed Web of Science ®Google Scholar
• Calender A., Billard M., Aubry J. P., Banchereau J., Vuillaume M., Lenoir G. M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 1987; 84: 8060–8064
   PubMed Web of Science ®Google Scholar
• Gordon J., Guy G. R. The molecules controlling B lymphocytes. Immunol. Today 1987; 8(11)339–344
   PubMedGoogle Scholar
• Walker L., Gordon J. A detailed kinetic study on the appearance of surface antigens defined by the workshop activation panel following the stimulation of purified Go B-lymphocytes. Leucocyte Typing III, McMichael, et al. Oxford University Press, Oxford 1987; 555–557
   Google Scholar
• Freedman A. S., Boyd A. W., Berrebi A., Horowitz J. C., Levy D. N., Rosen K., Daley J., Slaughenhoupt B., Levine H., Nadler L. M. Expression of B cell activation antigens on normal and malignant B cells. Leukaemia 1987; 1(1)9–15
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Muraguchi A., Butler J. L., Falkoff R. J. M., Fauci A. S. Human B cell activation, proliferation and differentiation. Immunol. Rev. 1984; 78: 75–96
   PubMed Web of Science ®Google Scholar
• Neckers L. M., Yenokida G., James S. P. The role of the transferrin receptor in human B lymphocyte activation. J. Immunol. 1984; 133: 2437–2441
   PubMed Web of Science ®Google Scholar
• Anderson K. C., Bates M. P., Slaughenhoupt B., Schlossman S. F., Nadler L. M. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J. Immunol. 1984; 132: 3172–3179
   PubMed Web of Science ®Google Scholar
• Tong A. W., Lee J. C., Stone M. J. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells. Blood 1987; 69(1)238–245
   PubMed Web of Science ®Google Scholar
• Bhan A. K., Nadler L. M., Stashenko P., McClusky R. T., Schlossman S. F. Stages of B cell differentiation in human lymphoid tissue. J. exp. Med. 1981; 154: 737–749
   PubMed Web of Science ®Google Scholar
• Guy K., Van Heyningen V. An ordered sequence of expression of MHC class-II antigens during B-cell maturation. Immunology Today 1983; 4: 186–189
   PubMedGoogle Scholar
• Guy K., Krajewski A. S., Dewar A. E. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br. J. Cancer 1986; 53: 161–173
   PubMed Web of Science ®Google Scholar
• Hunkapillar T., Hood L. The immunoglobulin superfamily. Adv. in Immunol. 1989; 44: 1–63
   PubMed Web of Science ®Google Scholar
• Williams A. F. Immunoglobulin-related domains for cell surface recognition. Nature 1985; 314: 579–580
   PubMed Web of Science ®Google Scholar
• Williams A. F., Barclay A. N. The immunoglobulin superfamily-domains for cell surface recognition. Ann. Rev. Immunol. 1988; 6: 381–405
   PubMed Web of Science ®Google Scholar
• Hunkapiller T., Hood L. The growing immunoglobulin gene superfamily. Nature 1986; 323: 15–16
   PubMed Web of Science ®Google Scholar
• Hood L., Kronenberg M., Hunkapiller T. T cell antigens and the immunoglobulin supergene family. Cell 1985; 40: 225–229
   PubMed Web of Science ®Google Scholar
• Hynes R. O. Integrins, a family of cell surface receptors. Cell 1987; 48: 549–554
   PubMed Web of Science ®Google Scholar
• Hogg N. The leukocyte integrins. Immunology Today 1989; 10(4)111–114
   PubMedGoogle Scholar
• Rouslahti E., Pierschbacher M. D. Arg-Gly-Asp: a versatile cell recognition signal. Cell 1986; 44: 517–518
   PubMed Web of Science ®Google Scholar
• Hemler M. E. Adhesive protein receptors on hematopoietic cells. Immunology Today 1988; 9(4)109–113
   PubMedGoogle Scholar
• Springer T. A., Dustin M. L., Kishmoto T. K., Marlin S. D. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: Cell adhesion receptors of the immune system. Ann. Rev. Immunol. 1987; 5: 223–252
   PubMed Web of Science ®Google Scholar
• Inghirami G., Wieczorek R., Zhu B-Y., Silber R., Dalla-Favera R., Knowles D. M. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukaemia. Blood 1988; 72(4)1431–1434
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Dunn S. M., Fecondo J. V., Culvenor J. G., Duhrsen U., Burns G. F., Wawryk S. O. Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood 1989; 73(7)1896–1903
   PubMed Web of Science ®Google Scholar
• Wawryk S. O., Novotny J. R., Wicks I. P., Wilkinson D., Maher D., Salvaris E., Welch K., Fecondo J. V., Boyd A. W. The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol. Rev. 1989; 108: 135–161
   PubMed Web of Science ®Google Scholar
• Dustin M. L., Staunton D. E., Springer T. A. Supergene families meet in the immune system. Immunology Today 1988; 9: 213–215
   PubMedGoogle Scholar
• Gallatin M., St. John T. P., Siegelman M., Reichert R., Butcher E. C., Weissman I. L. Lymphocyte homing receptors. Cell 1986; 44: 637–680
   Web of Science ®Google Scholar
• Jalkanen S., Wu N., Baragatze R. F., Butcher E. C. Human lymphocyte and lymphoma homing receptors. Ann. Rev. Med. 1987; 38: 467–476
   PubMed Web of Science ®Google Scholar
• Sher B. T., Bargatze R., Holzmann B., Gallatin W. M., Matthews D., Wu N., Picker L., Butcher E. C., Weissman I. L. Homing receptors and metastasis. Adv. in Cancer Research 1988; 51: 361–391
   PubMed Web of Science ®Google Scholar
• Yednock T. A., Rosen S. D. Lymphocyte homing. Adv. in Immunol. 1989; 44: 313–378
   PubMed Web of Science ®Google Scholar
• Berg E. L., Goldstein L. A., Jutila M. A., Nakache M., Picker L. J., Streeter P. R., Wu N. W., Zhou D., Butcher E. C. Homing receptors and vascular addressins: Cell adhesion molecules that direct lymphocyte traffic. Immunol. Rev. 1989; 108: 5–18
   PubMed Web of Science ®Google Scholar
• Stoolman L. M. Adhesion molecules controlling lymphocyte migration. Cell 1989; 56: 907–910
   PubMed Web of Science ®Google Scholar
• Goldstein L. A., Zhou D. F. H., Picker L. J., Minty C. N., Bargatze R. F., Ding J. F., Butcher E. C. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989; 56: 1063–1072
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Amiot M., Pesandro J. M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56: 1057–1062
   PubMed Web of Science ®Google Scholar
• Lasky L. A., Singer M. S., Yednock T. A., Dowbenko D., Fennie C., Rodriguez H., Nguyen T., Stachel S., Rosen S. D. Cloning of a lymphocyte homing receptor reveals a lectin domain. Cell 1989; 56: 1045–1055
   PubMed Web of Science ®Google Scholar
• Siegelman M. H., van de Rijn M., Weissman I. L. Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. Science 1989; 243: 1165–1172
   PubMed Web of Science ®Google Scholar
• Johnson G. I., Cook R. G., McEver R. P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56: 1033–1044
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Stengelin S., Gimbrone M. A., Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160–1164
   PubMed Web of Science ®Google Scholar
• Holzmann B., McIntyre B. W., Weissman I. L. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell 1989; 56: 37–46
   PubMed Web of Science ®Google Scholar
• Holzmann B., Weissman I. L. Peyer's patchspecific lymphocyte homing receptors consist of a VLA-4-like α chain associated with either of two integrin β chains, one of which is novel. EMBO 1989; 8(6)1735–1741
   PubMed Web of Science ®Google Scholar
• Pals S. T., Horst E., Ossekoppele G. J., Figdor C. G., Scheper R. J., Meijer C. J.L. M. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 1989; 73(4)885–888
   PubMed Web of Science ®Google Scholar
• Pals S. T., Horst E., Scheper R. J., Meijer C. J. L. M. Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol. Rev. 1989; 108: 111–133
   PubMed Web of Science ®Google Scholar
• Picker L. J., Medeiros L. J., Weiss L. M., Warnke R. A., Butcher E. C. Expression of lymphocyte homing receptor antigen in Non-Hodgkin's lymphoma. Am. J. Pathol. 1988; 130(3)496–504
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders. Adv. Immunol. 1987; 40: 247–321
   PubMed Web of Science ®Google Scholar
• Griesser H., Tkachuk D., Reiss M. D., Mak T. W. Gene rearrangements and translocations in lymphoproliferative diseases. Blood 1989; 73(6)1402–1415
   PubMed Web of Science ®Google Scholar
• Honjo T. Immunoglobulin genes. Ann. Rev. Immunol. 1983; 1: 499–528
   PubMed Web of Science ®Google Scholar
• Hieter P. A., Max E. E., Seidman J. C., Maizel J. V., Jr., Leder P. Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 1980; 22: 197–207
   PubMed Web of Science ®Google Scholar
• Hieter P. A., Maizel J. V., Jr., Leder P. Evolution of human κ J region genes. J. Biol. Chem. 1982; 257(3)1516–1522
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Korsmeyer S. J., Bakashi A., Arnold A., Kisch I. R. Molecular genetic analysis of human lymphoid neoplasia. Immunoglobulin genes and the c-myc oncogene. Annals Int. Med. 1985; 102: 497–510
   PubMed Web of Science ®Google Scholar
• Solomon A. Light chains of immunoglobulins: structural-genetic correlates. Blood 1986; 68(3)603–610
   PubMed Web of Science ®Google Scholar
• Hieter P. A., Hollis G. F., Korsmeyer S. J., Waldmann T. A., Leder P. Clustered arrangement of immunoglobulin λ constant region genes in man. Nature 1981; 294: 536–540
   PubMed Web of Science ®Google Scholar
• Ravetch J. V., Seibenlist U., Korsmeyer S. J., Waldmann T. A., Leder P. Structure of the human μ locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 26: 583
   Web of Science ®Google Scholar
• Alt F. W., Blackwell K., Yancopoulos G. D. Development of the primary antibody repertoire. Science 1987; 238: 1079–1087
   PubMed Web of Science ®Google Scholar
• Golub E. S. Somatic mutation: diversity and regulation of the immune system. Cell 1987; 48: 723–724
   PubMed Web of Science ®Google Scholar
• Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575–581
   PubMed Web of Science ®Google Scholar
• Teale J. M., Abraham K. M. The regulation of antibody class expression. Immunology Today 1987; 8(4)122–126
   PubMedGoogle Scholar
• Calame K. L. Mechanisms that regulate immunoglobulin gene expression. Ann. Rev. Immunol. 1985; 3: 159–195
   PubMed Web of Science ®Google Scholar
• Maniatis T., Goodbourn S., Fischer J. A. Regulation of inducible and tissue-specific gene expression. Science 1987; 236: 1237–1245
   PubMed Web of Science ®Google Scholar
• Wall R., Keuhl M. Biosynthesis and regulation of immunoglobulins. Ann. Rev. Immunol. 1983; 1: 393–422
   PubMed Web of Science ®Google Scholar
• Rogers J., Wall R. Immunoglobulin RNA rearrangements in B lymphocyte differentiation. Adv. Immunol. 1984; 35: 39–59
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Hieter P. A., Ravetch J. V., Poplack D. G., Waldman T. A., Leder P. Developmental hierachy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc. Natl. Acad. Sci. USA 1981; 78(11)7096–7100
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Hierarchy of immunoglobulin gene rearrangements in B-cell leukaemias. In Waldmann, T. A. (moderator) Molecular genetic analyses of human lymphoid neoplasms: immunoglubulin genes and the c-myc oncogene. Ann. Int. Med. 1985; 102: 497–510
   PubMedGoogle Scholar
• Hieter P. A., Korsmeyer S. J., Waldmann T. A., Leder P. Human immunoglublin κ light-chain genes are deleted or rearranged in λ-producing B cells. Nature 1981; 290: 368–372
   PubMed Web of Science ®Google Scholar
• Coleclough C., Perry R. P., Karjalainen K., Weigert M. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature 1981; 290: 372–378
   PubMed Web of Science ®Google Scholar
• Arnold A., Cassman J., Baklishi A., Jaffe E. S., Waldmann T. A., Korsmeyer S. J. Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. New Engl. J. Med. 1983; 309: 1593–1599
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Chao J., Warnke R., Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B cell lymphoma. Proc. Nat. Acad. Sci. 1984; 81: 593–597
   PubMed Web of Science ®Google Scholar
• Hu E., Trela M., Thompson J. M., Lowder J., Horning S., Levy R., Sklar J. Detection of B-cell lymphoma in peripheral blood by DNA hybridisation. Lancet 1985; ii: 1092–1095
   Google Scholar
• Foroni L., Catovsky D., Rabbitts T. H., Luzatto L. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. Mol. Biol. Med. 1984; 2: 63–79
   PubMedGoogle Scholar
• Yunis J. J., Oken M. M., McKenna J., Theologides A., Arnesen M., Frizzera G. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. New Engl. J. Med. 1987; 316: 79–84
   PubMed Web of Science ®Google Scholar
• Klein G., Klein E. Evolution of tumours and the impact of molecular oncology. Nature 1985; 315: 190–195
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Biological implications of consistent chromosomal rearrangements in leukaemia and lymphoma. Cancer Research 1984; 44: 3159–3168
   PubMed Web of Science ®Google Scholar
• Croce C. M. Role of chromosomal translocations in human neoplasia. Cell 1987; 49: 155–156
   PubMed Web of Science ®Google Scholar
• Croce C. M., Nowell P. C. Molecular genetics of human B cell neoplasia. Adv. Immunol. 1986; 38: 245–274
   PubMedGoogle Scholar
• Croce C., Nowell P. C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1–7
   PubMed Web of Science ®Google Scholar
• Langdon W. Y., Harris A. W., Cory S., Adams J. M. The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice. Cell 1986; 47: 11–18
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Gorham J., Cossman J., Jaffe E., Croce C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390–1393
   PubMed Web of Science ®Google Scholar
• Rabbitts P. H., Douglas J., Fischer P., Nacheva E., Karpas A., Catovsky D., Melo J. V., Baer R., Stinson M. A., Rabbitts T. H. Chromosome abnormalities at 11q13 in B cell tumours. Oncogene 1988; 3: 99–103
   Web of Science ®Google Scholar
• Neoplastic Disease of the Blood, P. H. Wiernik, G. Canellos, R. A. Kyle, A. Schiffer. Churchill Livingstone, New York 1985
   Google Scholar
• Catovsky D. Chronic lymphocytic, prolymphocytic and hairy cell leukaemias. Leukaemias, J. M. Goldman, H. D. Preisler. Butterworths, London 1984; 266–298
   Google Scholar
• Chronic lymphocytic leukaemia, A. Polliack, D. Catovsky. Harwood Academic Publishers, ChurSwitzerland 1988
   Google Scholar
• Galton D. A. G., MacLennan I. C. M. Clinical Patterns in B lymphoid malignancy. Clinics in Haematol. 1982; 11(3)561–587
   PubMedGoogle Scholar
• Foon K. A., Todd R. F., III. Immunologic classification of leukaemia and lymphoma. Blood 1986; 68(1)1–31
   PubMed Web of Science ®Google Scholar
• Nadler L. M., Korsmeyer S. J., Anderson K. C., Boyd A. W., Slaughenhoupt B., Park E., Jensen J., Coral F., Mayer R. J., Sallan S. E., Ritz J., Schlossman S. F. B cell origin of non-T acute lymphoblastic leukaemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J. Clin. Invest. 1984; 74: 332–340
   PubMed Web of Science ®Google Scholar
• Anderson K. C., Bates M. P., Slaughenhoupt B., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukaemias and lymphomas: a model of human B cell differentiation. Blood 1984; 63: 1424–1433
   PubMed Web of Science ®Google Scholar
• Hurwitz C. A., Loken M. R., Graham M. L., Karp J. E., Borowitz M. J., Pullen D. J., Civin C. I. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988; 72(1)299–307
   PubMed Web of Science ®Google Scholar
• Gale R. P., Foon K. Chronic lymphocytic leukaemia. Annals Int. Med. 1985; 103: 101–120
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Nadler L. M. B cell development in chronic lymphocytic leukaemia. Semin. Haematol. 1987; XXIV(4)230–239
   Google Scholar
• Foon K. A., Gale R. P. Staging and therapy of chronic lymphocytic leukaemia. Semin. Haematol. 1987; XXIV(4)264–274
   Google Scholar
• Freedman A. S., Boyd A. W., Bieber F. R., Daley J., Rosen K., Horowitz J. C., Levy D. N., Nadler L. M. Normal cellular counterparts of B cell chronic lymphocytic leukaemia. Leukemia 1987; 70(2)418–427
   Google Scholar
• Gale R. P., Foon K. A. Biology of chronic lymphocytic leukaemia. Semin. Haematol., XXIV(4)209–229
   Google Scholar
• Caligaris-Cappio F., Janossy G. Surface markers in chronic lymphocytic leukaemia of B cell type. Semin. Haematol. 1985; XX: 1–12
   Google Scholar
• Carlsson M., Totterman T. H., Matsson P., Nilsson K. Cell cycle progression of B-chronic lymphocytic leukaemia cells induced to differentiate by TPA. Blood 1988; 71(2)415–421
   PubMed Web of Science ®Google Scholar
• Gadol N., Ault K. A. Phenotypic and functional characterization of human Leul (CD5) B cells. Immunol. Rev. 1986; 93: 23–24
   PubMed Web of Science ®Google Scholar
• Galton D. A. G., Goldman J. M., Wiltshaw E., Catovsky D., Henry K., Goldenberg J. Prolymphocytic leukaemia. Br. J. Haematol. 1974; 27: 7–23
   PubMed Web of Science ®Google Scholar
• Melo J. V., Catovsky D., Galton D. A. G. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br. J. Haematol. 1986; 63: 377–387
   PubMed Web of Science ®Google Scholar
• Melo J. V., Catovsky D., Galton D. A. G. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: II. Patterns of evolution of 'prolymphocytoid' transformation. Br. J. Haematol. 1986; 64: 77–86
   PubMed Web of Science ®Google Scholar
• Brooks D. A., Beckman I. G. R., Bradley J., McNamara P. J., Thomas M. E., Zola H. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J. Immunol. 1981; 126(4)1373–1377
   PubMed Web of Science ®Google Scholar
• Zola H., Moore H. A., Hohmann H., Hunter I. K., Nikoloutsopoulos A., Bradley J. The antigen of mature human B cells detected by the monoclonal antibody FMC-7: Studies on the nature of the antigen and modulation of its expression. J. Immunol. 1984; 133(1)321–326
   PubMed Web of Science ®Google Scholar
• Catovsky D., Cherchi M., Brooks D., Bradley J., Zola H. Heterogeneity of B cell leukaemias demonstrated by the monoclonal antibody FMC-7. Blood 1981; 58(2)406–408
   PubMed Web of Science ®Google Scholar
• Enno A., Catovsky D., O'Brien M., Cherchi M., Kumaran T. O., Galton D. A. G. 'Prolymphocytoid' transformation of chronic lymphocytic leukaemia. Br. J. Haematol. 1979; 41: 9–18
   PubMed Web of Science ®Google Scholar
• Bournoncle B. Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 1979; 53(3)412–435
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Worman C. P. Hairy cell leukaemia. Br. J. Haematol. 1985; 60: 213–218
   PubMed Web of Science ®Google Scholar
• Jansen J. Hairy cell leukaemia. CRC Critical Reviews in Oncology/Hematology 1987; 7(3)183–217
   PubMed Web of Science ®Google Scholar
• Anderson K. C., Boyd A. W., Fisher D. C., Leslie D., Schlossman S. F., Nadler L. M. Hairy cell leukemia: a tumor of pre-plasma cells. Blood 1985; 65(3)620–629
   PubMed Web of Science ®Google Scholar
• Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. J. exp. Med. 1984; 160: 612–617
   PubMed Web of Science ®Google Scholar
• Jung L. K. L., Hora T., Fu M. Detection and functional studies of p60–65 (Tac antigen) on activated human B cells. J. exp. Med. 1984; 160: 1597–1602
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Goldman C. K., Robb R. J., Dopper J. M., Leonard W. S., Sharrow S. C., Bongiovanni K. F., Korsmeyer S. J., Greene W. C. Expression of inter-leukin 2 receptors on activated human B cells. J. exp. Med. 1984; 160: 1450–1466
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Chiorazzi N., Kunkel H. G. Monoclonal antibodies with specificity for hairy cell leukaemia cells. J. Clin. Invest. 1982; 70: 254–261
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Wang C. Y., Chiorazzi N., Crow M. K., Kunkel H. G. An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. J. Immunol. 1984; 133: 1635–1640
   PubMed Web of Science ®Google Scholar
• Visser L., Shaw A., Slupsky J., Vos H., Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood 1989; 74(1)320–325
   PubMed Web of Science ®Google Scholar
• Golomb H. M. The treatment of hairy cell leukaemia. Blood 1987; 69(4)979–983
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Rueben J., Manning J. T., Hersh E. M., Gutterman J. V. Alpha interferon for induction of remission in hairy cell leukaemia. New Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Spiers A. S. D., Parekh S. J., Ramnes C. R., Cassileth P. A., Oken M. M. Hairy cell leukaemia (HCL): pentostatin (dCF, 2'-deoxycoformycin) is effective both as initial treatment and after failure of splenectomy and alpha interferon. Blood 1985; 66(Suppl. 1)208a
   Google Scholar
• Catovsky D., O'Brien M., Melo J. V., Wardle J., Brosovic M. Hairy cell leukaemia (HCL) variant: an intermediate disease between HCL and B-prolymphocytic leukaemia. Semin. Oncol. 1984; 11: 362–369
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Burns G. F., Hayhoe F. G. J. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy cell leukaemia. Leukaemia Research 1980; 4: 547–559
   PubMed Web of Science ®Google Scholar
• Sainati L., Robinson D., Crawford A., Catovsky D. A variant form of hairy cell leukaemia. A report of 15 cases. Br. J. Haematol. 1989; 71: 24a
   Google Scholar
• Melo J. V., Robinson D. S. F., Gregory C., Catovsky D. Splenic B cell lymphoma with “villous” lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukaemia. Leukaemia 1987; 1(4)294–299
   PubMed Web of Science ®Google Scholar
• Melo J. V., Hegde U., Parriera A., Thompson I., Lampert I. A., Catovsky D. Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J. Clin. Pathol. 1987; 40: 642–651
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Dearden C., Mills M., Traub N., Hegde U., Behrens J., Catovsky D. The treatment of splenic lymphoma with villous lymphocytes. A report of 25 cases. Br. J. Haematol. 1989; 71: 26a
   Google Scholar
• National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Spiro S., Galton D. A. G., Wiltshaw E., Lohmann R. C. Follicular lymphoma; a survey of 75 cases with special reference to the syndrome resembling a chronic lymphocytic leukaemia. Br. J. Haematol. 1975; 31(Suppl II)60–72
   Google Scholar
• Come S. E., Jaffe E. S., Anderson J. C., Mann R. B., Johnson B. L., DeVita V. T., Young R. C. Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. Am. J. Med. 1980; 69: 667–674
   PubMed Web of Science ®Google Scholar
• Melo J. V., Robinson D. S. F., de Olivera M. P., Thompson I. W., Ng J. P., Galton D. A. G., Catovsky D. Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. J. Clin. Pathol. 1988; 41: 951–959
   PubMed Web of Science ®Google Scholar
• Freedmann A. S., Boyd A. W., Anderson K. C., Fisher D. C., Pinkus G. S., Schlossman S. F., Nadler L. M. Immunologic heterogeneity of diffuse large cell lymphoma. Blood 1985; 65(3)630–637
   PubMed Web of Science ®Google Scholar
• Trowbridge I. S., Ornery M. B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. USA 1981; 78: 3039–3043
   PubMed Web of Science ®Google Scholar
• Habeshaw J. A., Lister T. A., Greaves M. F. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin's lymphoma. Lancet 1983; i: 498–500
   Google Scholar
• Pileri S., Gobbi M., Rovano M. T., Martinelli G. Immunohistological study of transferrin receptor expression in non-Hodgkin's lymphoma. Br. J. Haematol. 1984; 58: 501–508
   PubMed Web of Science ®Google Scholar
• Mellstedt H., Holm G., Bjorkholm M. Multiple myeloma, Waldenstrom's macroglobulinaemia and benign monoclonal gammopathy. Characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. Adv. Cancer Res. 1984; 41: 257–289
   PubMed Web of Science ®Google Scholar
• Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma-new biological insights and advances in therapy. Blood 1989; 73(3)865–879
   PubMedGoogle Scholar
• Ruiz-Arguelles G. J., Katzmann J. A., Greipp P. R., Goncheroff N. J., Gorton J. P., Kyle R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood 1984; 64: 352–356
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Durie B. G. M., Lomen C., Spier C., Wirt D. P., Nagle R., Wilson G. S., Richter L., Vela E., Maxey V., McDaniel K., Rangel C. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features. Blood 1987; 70(4)932–942
   PubMed Web of Science ®Google Scholar
• Epstein J., Barlogie B., Katzmann J., Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 1988; 71(4)861–865
   PubMed Web of Science ®Google Scholar
• King K. A., Nelson D. S. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. Blood 1989; 73(7)1925–1935
   PubMed Web of Science ®Google Scholar
• Kosma M. A., Gale R. P. Plasma cell leukaemia. Semin. Haematol. 1987; 24(3)202–208
   Web of Science ®Google Scholar